These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 3074631
1. Immunochemical studies of human placental alkaline phosphatase in normal and neoplastic tissues. Vengerov YuYu, Gudima SO, Voronov AV, Votrin II. Adv Enzyme Regul; 1988; 27():345-54. PubMed ID: 3074631 [Abstract] [Full Text] [Related]
2. Human placental alkaline phosphatase in benign and malignant ovarian neoplasia. Nouwen EJ, Pollet DE, Schelstraete JB, Eerdekens MW, Hänsch C, Van de Voorde A, De Broe ME. Cancer Res; 1985 Feb; 45(2):892-902. PubMed ID: 3967249 [Abstract] [Full Text] [Related]
4. Use of monoclonal antibodies to detect human placental alkaline phosphatase. De Groote G, De Waele P, Van de Voorde A, De Broe M, Fiers W. Clin Chem; 1983 Jan; 29(1):115-9. PubMed ID: 6336677 [Abstract] [Full Text] [Related]
7. Placental-like alkaline phosphatase from ovary and ascites of a patient with a malignant ovarian tumour. Koyama I, Stendahl U, Stigbrand T. Clin Chim Acta; 1990 Jan 15; 186(2):295-9. PubMed ID: 2311257 [No Abstract] [Full Text] [Related]
11. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer]. Neumann A, Keller T, Jocham D, Doehn C. Aktuelle Urol; 2011 Sep 15; 42(5):311-5. PubMed ID: 21809268 [Abstract] [Full Text] [Related]
12. Screening of sera and tumor extracts of cancer patients using a monoclonal antibody directed against human placental alkaline phosphatase. Van de Voorde A, de Groote G, de Waele P, de Broe ME, Pollet D, de Boever J, Vandekerckhove D, Fiers W. Eur J Cancer Clin Oncol; 1985 Jan 15; 21(1):65-71. PubMed ID: 3882432 [Abstract] [Full Text] [Related]
16. Immunohistochemical localization of placental alkaline phosphatase, carcinoembryonic antigen, and cancer antigen 125 in normal and neoplastic human lung. Nouwen EJ, Pollet DE, Eerdekens MW, Hendrix PG, Briers TW, De Broe ME. Cancer Res; 1986 Feb 15; 46(2):866-76. PubMed ID: 3510076 [Abstract] [Full Text] [Related]
17. Immunohistology of normal and ovarian cancer tissue with a monoclonal antibody to placental alkaline phosphatase. Sunderland CA, Davies JO, Stirrat GM. Cancer Res; 1984 Oct 15; 44(10):4496-502. PubMed ID: 6467208 [Abstract] [Full Text] [Related]
18. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: relevance for differential diagnosis. Tholander B, Taube A, Lindgren A, Sjöberg O, Stendahl U, Kiviranta A, Hallman K, Holm L, Weiner E, Tamsen L. Gynecol Oncol; 1990 Oct 15; 39(1):16-25. PubMed ID: 2227569 [Abstract] [Full Text] [Related]
19. Binding of specific peroxidase-labeled antibody to placental-type phosphatase on tumor-derived membrane fragments. Taylor DD, Homesley HD, Doellgast GJ. Cancer Res; 1980 Nov 15; 40(11):4064-9. PubMed ID: 7008934 [Abstract] [Full Text] [Related]
20. The value of a sensitive assay of carcino-placental alkaline phosphatase (CPAP) in the follow-up of gynecological cancers. Haije WG, Meerwaldt JH, Talerman A, Kuipers Tj, Baggerman L, Teeuw AH, van der Pompe WB, van Driel J. Int J Cancer; 1979 Sep 15; 24(3):288-93. PubMed ID: 385513 [Abstract] [Full Text] [Related] Page: [Next] [New Search]